Cidara Therapeutics skyrockets 1,165% after positive CD388 data and Merck's acquisition bid. Read why CDTX stock is a Hold.

Calling it the “Health Care Medical Freedom Act,” a House Republican on Monday filed a bill that says health-care providers ...

A House Republican has filed a bill that says health-care providers could not “discriminate” against patients based on ...

The new bill, called the "Health Care Medical Freedom Act," would, in part, prohibit Florida providers from refusing to see ...

The past year saw a number of significant actions at the state and federal levels that could transform how health care is ...

CX-5461 is the first G-quadruplex (G4) stabilizer in development. It has shown promising activity in early-phase trials for ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Travere Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The latest announcement is out from Adlai Nortye Ltd. Sponsored ADR ( ($ANL) ). On December 29, 2025, Adlai Nortye Ltd. announced an exclusive ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Enhertu (trastuzumab deruxtecan) has now been approved in China for the treatment of adult patients with unresectable or ...